Novo Nordisk marketed insulin pen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novo Nordisk marketed insulin pen, covering 2017-03-27 to 2017-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics [Phase 3]